A study evaluating safety of inflammatory bowel disease patients receiving vedolizumab perioperatively.
Phase of Trial: Phase IV
Latest Information Update: 06 Jan 2017
At a glance
- Drugs Vedolizumab (Primary) ; Infliximab
- Indications Crohn's disease; Inflammatory bowel diseases; Ulcerative colitis
- Focus Adverse reactions
- 06 Jan 2017 New trial record